Skip to content

Randomised trial comparing advanced airway management during in-hospital cardiac arrest

Randomised trial of the clinical and cost-effectiveness of a supraglottic airway device versus intubation in-hospital cardiac arrest

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17720457
Enrollment
4190
Registered
2022-07-29
Start date
2022-09-01
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

In-hospital cardiac arrest that requires advanced airway management Circulatory System

Interventions

The researchers will be using a bespoke progressive web application (PWA) to randomise. Intervention: A supraglottic airway device of the type used routinely in that hospital. During resuscitation th

Sponsors

University Hospitals Bristol and Weston NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Adult (known or believed to be age =18 years) 2. In-hospital cardiac arrest, attended by the hospital cardiac arrest team in response to a cardiac arrest call (2222 or equivalent), and including a clinician permitted to undertake tracheal intubation and supraglottic airway placement so that either intervention can be delivered 3. Undergoing resuscitation and requiring advanced airway management in the opinion of the clinician managing the patient’s airway

Exclusion criteria

Exclusion criteria: Current exclusion criteria as of 02/08/2024: 1. Patients who have a cardiac arrest outside hospital and who are transported to the hospital in ongoing cardiac arrest 2. People who are not a hospital inpatient (e.g. visitor, relative, staff or outpatient) 3. Patients already receiving advanced airway management (including a supraglottic airway device) at the time of eligibility assessment 4. Patients known to be pregnant 5. Patients with a functioning tracheostomy _____ Previous exclusion criteria: 1. Patients in the emergency department 2. People who are not a hospital inpatient (e.g. visitor, relative, staff or outpatient) 3. Patients already receiving advanced airway management (including a supraglottic airway device) at the time of eligibility assessment 4. Patients known to be pregnant 5. Patients with a functioning tracheostomy

Design outcomes

Primary

MeasureTime frame
Functional status as measured by the modified Rankin Scale (mRS) at hospital discharge (or 30 days post-randomisation whichever is shorter)

Secondary

MeasureTime frame
1. Initial ventilation success measured using data collected from site staff into a bespoke application at baseline 2. Regurgitation/aspiration during resuscitation measured using data collected from site staff into a bespoke application at baseline 3. Return of spontaneous circulation (ROSC) >20 minutes measured using data collected from site staff into a bespoke application at baseline 4. ICU and hospital length of stay measured using data linkage from National Cardiac Arrest Audit (NCAA) at hospital discharge 5. Health-related quality of life measured using EQ5D-5L questionnaire at discharge, 3 and 6 months 6. Survival to hospital discharge, 3 months and 6 months measured using data linkage from NCAA and Office for National Statistics (ONS) death registry 7. Functional status (mRS) measured using the modified Rankin Scale (mRS) at 3 and 6 months

Countries

England, United Kingdom, Wales

Contacts

Public ContactJannat Chowdhury
airways3@warwick.ac.uk+44 (0)7385083320

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026